A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment

• Status: Recruiting
• Trial end date: 2022-05-01

Summary

A phase 1 clinical trial to evaluate safety, PK/PD profiles and food effects of URC102 in patients with renal impairment and healthy people.

• Phase: Phase 1

Details

• Lead Sponsor: JW Pharmaceutical